BIOCRYST PHARMACEUTICALS INC (BCRX)

US09058V1035 - Common Stock

5.82  +0.17 (+3.01%)

After market: 5.8 -0.02 (-0.34%)

Buy % Consensus

81

ChartMill assigns a Buy % Consensus number of 81% to BCRX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 14.09. This target is 142.17% above the current price.
BCRX was analyzed by 18 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about BCRX.
In the previous month the buy percentage consensus was at a similar level.
BCRX was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 5.826.0611.2214.0931.50 - 4.12% 92.78% 142.17% 441.24%
Up and Down Grades
Date Firm Action Rating
2024-01-08 Needham Reiterate Buy -> Buy
2023-11-20 JP Morgan Reiterate Overweight
2023-11-06 Needham Reiterate Buy -> Buy
2023-09-25 RBC Capital Reiterate Outperform -> Outperform
2023-09-18 RBC Capital Upgrade Sector Perform -> Outperform
2023-08-04 RBC Capital Maintains Sector Perform -> Sector Perform
2023-08-04 Jefferies Upgrade Hold -> Buy
2023-08-04 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-03 Needham Reiterate Buy
2023-07-13 B of A Securities Upgrade Neutral -> Buy
2023-05-04 Needham Reiterate Buy
2023-05-04 RBC Capital Reiterate Sector Perform
2023-04-20 Needham Reiterate Buy
2023-04-20 Evercore ISI Group Maintains Outperform
2023-03-14 RBC Capital Reiterate Sector Perform
2023-02-22 JMP Securities Reiterate Market Outperform
2023-02-22 Needham Upgrade Hold -> Buy
2023-02-22 HC Wainwright & Co. Reiterate Buy
2022-11-02 RBC Capital Maintains Sector Perform
2022-11-02 Evercore ISI Group Upgrade In-Line -> Outperform
2022-08-08 Oppenheimer Downgrade Outperform -> Perform
2022-08-05 Oppenheimer Downgrade Outperform -> Perform
2022-08-05 Barclays Maintains Equal-Weight
2022-08-05 Evercore ISI Group Downgrade Outperform -> In-Line
2022-04-18 Barclays Downgrade Overweight -> Equal-Weight
2022-04-12 RBC Capital Maintains Sector Perform
2022-04-11 Oppenheimer Maintains Outperform
2022-04-11 B of A Securities Downgrade Buy -> Neutral
2021-12-10 Oppenheimer Initiate Outperform
2021-11-04 RBC Capital Maintains Sector Perform